The largest database of trusted experimental protocols

21 protocols using fitc anti human cd14

1

Macrophage Phenotyping in FB Arecoline Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The supernatant of FBs stimulated by arecoline was used as the conditioned medium for the experimental group whereas the supernatant of FBs without arecoline stimulation was utilized as the conditioned medium for the control group. After 48 h of treatment, the samples were analysed by flow cytometry. Cell density was adjusted to 1 × 107 cells/mL, then macrophages incubated with FITC anti‐human CD14, PE anti‐human CD68, APC anti‐human CD209, PE anti‐human CD163, Cy5 anti‐human CD206 (BioLegend). Finally, the cells were detected with flow cytometry (Cyto‐Flex Beckman).
+ Open protocol
+ Expand
2

Macrophage Phenotype Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tMACs or iMACs were stimulated with LPS and IFN-γ for the indicated time. The single-cell suspensions were then prepared and incubated with an antibody or antibody cocktails for 15 min at room temperature for cell surface staining. Antibodies used in this study were PE Mouse IgG1, κ isotype (Biolegend, Cat: 400113, Clone: MOPC-21, Lot: B245984), APC Mouse IgG1, κ isotype (Biolegend, Cat: 400119, Clone: MOPC-21, Lot: B243042), FITC Mouse IgG1, κ isotype (Biolegend, Cat: 400107, Clone: MOPC-21, Lot: B199152), APC anti-human CD206 (Biolegend, Cat: 321109, Clone: 15-2, Lot: B348965), APC anti-human CD86 (Biolegend, Cat: 305411, Clone: IT2.2, Lot: B351349), PE anti-human CD80 (Biolegend, Cat:305208, Clone: 2D10, Lot: B330518), PE anti-human CD163 (Biolegend, Cat: 333606, Clone: GHI/61, Lot: B347256), FITC anti-human CD14 (Biolegend, Cat: 325604, Clone: HCD14, Lot: B268830) and APC anti-humanCD11B (Biolegend, Cat: 301309, Clone: ICRF44, Lot: B278346). These antibodies were used at a 1:100 dilution. Data were recorded on Beckman DxFLEX and analyzed with the FlowJo V10 software.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometric Analysis of Immune Cell Phenotypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For surface staining, cells were washed and incubated with FITC-anti-human CD14 (BioLegend), PE-anti-human CD197 (BioLegend), APC-anti-human CD206 (BioLegend), or PerCP-5.5-anti-mouse F4/80 (BioLegend), PE-anti-mouse CD11b (BioLegend), APC-anti-mouse CD206 (BioLegend) in PBS containing 2% FBS at 4°C for 30 min. Isotype-matched immunoglobulin served as controls. For intracellular staining, cells were fixed with fixation buffer (BD Biosciences) for 30 min at 4°C. The fixed cells were permeabilized with the permeabilization solution (BD Biosciences) at room temperature for 30 min. Cells were incubated overnight with Alexa Fluor 488-anti-mouse iNOS (eBioscience) at 4°C. Then, labeled cells were sorted by using the Aria III cell sorter (BD Biosciences) or analyzed by using BD FACSCanto II (BD Biosciences) with FACSDiva software.
+ Open protocol
+ Expand
4

Multiparametric Phenotyping of Stimulated PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stimulated PBMCs were recovered from the culture plates and resuspended in 100 μL PBS. Cell viability was assessed by staining with Viobility™ Fixable Dyes (Miltenyi Biotec, Germany). Cells were washed, fixed, permeabilized, and then stained with an antibody cocktail containing Pacific Blue™ anti-human CD3 (Biolegend, clone: HIT3a), PE/Cyanine7 anti-human CD4 (Biolegend, clone:A161A1) and PerCP/Cyanine5.5 anti-human CD8 (Biolegend, clone: SK1) for T cell identification; APC anti-human CD69 (Biolegend, clone: FN50) and PE anti-human IFN-γ (Biolegend, clone:4S.B3) for the activation analysis; and FITC anti-human CD14 (Biolegend, clone:HCD14) and FITC anti-human CD20 (Biolegend, clone:2H7) for the exclusion of non-specific signals and B cells. Fifty thousand events were analyzed by a BD LSR-II flow cytometer. (BD Biosciences, San Jose, CA) The gates applied for the quantification of the stimulated T cells are illustrated in Figure S1.
+ Open protocol
+ Expand
5

Optimized Antibody Panel for Immunoblotting and Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for immunoblotting: Cell Signaling Technology, anti-p38 (Cat#: 8690), anti-p-p38 (Cat#: 4511), anti-p65 (Cat#: 8242), anti-p-p65 (Cat#: 3033), anti-JNK (Cat#: 9252), anti-p-JNK (Cat#: 4668), anti-Erk (Cat#: 4695), anti-p-Erk (Cat#: 4370), anti-PKM2 (Cat#: 4053), anti-STAT3 (Cat#: 12640); Abcam, anti-Pyk2 (Cat#: 228477); Santa Cruz Biotechnology, anti-p-Pyk2 (Cat#: sc-81512); Beyotime Institute of Biotechnology, anti-β-actin (Cat#: AA128), HRP labeled Goat Anti-Rabbit IgG (Cat#: A0208), HRP-labeled Goat Anti-Mouse IgG (Cat#: A0216). The following antibodies purchased from Biolegend were used for flow cytometry: FITC anti-mouse B220 (Cat#: 103206), BV421 anti-mouse CD11c (Cat#: 117330), FITC anti-mouse F4/80 (Cat#: 123108), APC anti-mouse CD86 (Cat#: 105012), PE anti-mouse CD40 (Cat#: 124610), PE anti-mouse GL7 (Cat#: 144607), APC anti-mouse CD95 (Cat#: 152604), APC anti-mouse CXCR5 (Cat#: 145506), PE anti-mouse PD-1 (Cat#: 135206), APC/Cy7 anti-human CD19 (Cat#: 302218), FITC anti-human CD14 (Cat#: 367116), BV421 anti-human CD11c (Cat#: 301628), APC anti-human CD86 (Cat#: 374208), PE anti-human CD40 (Cat#: 334308). All the antibodies for flow cytometry were used at a 1:100 dilution.
+ Open protocol
+ Expand
6

Differentiation of MUTZ-3 Cells into Immature Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MUTZ-3 cell line derived from a human acute myelomonocytic leukaemia (DSMZ, Braunschweig, Germany) was kept in minimal essential alpha medium (MEM α, Gibco) supplemented with 20% of heat-inactivated fetal bovine serum (FBS) and 50 U/ml of recombinant human GM-CSF (Miltenyi Biotec). To differentiate MUTZ-3 cells into iDCs, 1–2 × 105 cells/ml were incubated for 7 days in the presence of 300 U/ml human recombinant GM-CSF and IL-4 (Miltenyi Biotec)22 (link). LSRII flow cytometry was applied to analyse expression of surface markers (Fig. S1B), using FITC-anti-human CD14, PE-anti-human CD1a, PE/Cy7-anti-human DC-SIGN and APC-anti-human CD83 (all BioLegend, London, UK). Differentiated iDCs were kept in MEM α medium supplemented with 20% of heat-inactivated FBS during Aspergillus conidia interaction studies.
+ Open protocol
+ Expand
7

Multiparametric Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alexa Fluor® 700 anti-human CD3, (clone: HIT3a), FITC-anti human TCRαβ (clone: IP26), FITC-anti-human TCRγδ (clone: B1), APC/Cy7 Anti-Human CD127 (I-7Ra), (clone: A019D5), PE anti-human CD161, (clone: HP-3G10), Brilliant Violet 421TM anti-human CD117 (c-kit), (clone 104D2), PE/Cy7 anti-human CD294 (CRTH2), (clone: BM16), APC anti-human CD336 (NKp44), (clone: 325110), Alexa Fluor® 488 anti-human CD19, (clone: HIB19), FITC anti-human CD94, (clone:DX22), FITC anti-human CD1a, (clone: HI149), FITC anti-human CD11c, (clone: 3.9), FITC anti-human CD123, (clone: 6H6), anti-human CD303 (BDCA-2), (clone:201A), FITC anti-human CD14, (clone: 63D3), FITC anti-human FcεRIα, (clone: NP4D6), FITC anti-human CD34,(clone: 561), APC/Cy7 anti-human IFN-γ, (clone: 4S.B3) all from BioLegend. Anti-Human CD363 (S1PR1) eFluor® 660, (clone: SW4GYPP, ThermoFisher), Mouse IgG1 K Isotype Control eFluor® 660, (clone: P3.6.2.8.1, ThermoFisher). Anti-mouse CD3) APC, (clone: 17A2), anti-mouse NK1.1 Alexa Fluor® 647, (clone: PK136), anti-mouse B220 APC/Cy7 or FITC, (clone:RA3-6B2), anti-mouse CD45-Percp Cy5.5, (clone:30-F11), anti-mouse CD90.2 PE Cy7, (clone:30-H12), anti-mouse CD11b APC, (clone:M1/70), anti-mouse GATA3 PE (Clone: 16E10A23), anti-mouse Rorγt (Clone: 2F7-2).
+ Open protocol
+ Expand
8

Phenotyping of M1 and M2 Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescent staining for flow cytometric analysis of M1 or M2 was performed in FACS buffer (PBS with 0.5% BSA, 2 mM EDTA and 0.1% sodium azide). MDM were either treated with vehicle or 30 nM ArchA during 48 h polarization. Non-specific antibody binding was blocked by using mouse serum for 10 min at 4°C prior antibody staining. Subsequently, MDM were stained with fluorochrome-labelled antibody mixtures at 4 °C for 20 min. The following antibodies were used: FITC anti-human CD14 (2 μg/test, clone M5E2, Biolegend, San Diego, CA), PE anti-human CD54 (1 μg/test, clone HA58, eBioscience, San Diego, CA), APC-H7 anti-human CD80 (0.25 μg/test, clone L307.4, BD Bioscience), PE-Cy7 anti-human CD163 (2 μg/test, clone RM3/1, Biolegend), PerCP-eFluor710 anti-human CD206 (0.06 μg/test, clone 19.2, eBioscience). Upon staining, MDM (M1 or M2) were analyzed using a FACS Canto Plus flow cytometer (BD Bioscience), and data analyzed using FlowJo X Software (BD Bioscience).
+ Open protocol
+ Expand
9

Quantifying Immune Cell Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell surface staining of blood mononuclear cells and isolated monocytes was carried out by incubation with FITC antihuman CD14 and APC anti human CD14 (BioLegend, San Diego, CA, US). Expression of protein levels of IRAK-M was determined by flow cytometry intracellular staining. THP-1 cells and PBMCs were fixed and permeabilized (Transcription Factor Staining Buffer Set, Thermo Fisher Scientific, Waltham, MA, US). Then, staining was carried out with anti-human IRAK-M rabbit polyclonal antibody (ab-8116, Abcam) and anti-rabbit APC conjugated secondary antibody (BioLegend, San Diego, CA, US). The proper isotype control was used as a control. The flow cytometry events were acquired in a FACS Calibur (BD Biosciences, San Jose, CA) and analyzed with the use of Summit v4.3 Software.
+ Open protocol
+ Expand
10

Immune Cell Phenotyping and Cytokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were incubated with Human TruStain FcX (BioLegend, USA) and stained with the following antibodies: FITC anti-human CD14 and Alexa Fluor 647 anti-human CD16 (BioLegend, USA). The stained cells were assessed using the FACSCelesta (BD Biosciences, USA). Data were analyzed using FlowJo software (V10.6.2., Tree Star). Nine plasma proteins, including IL-6, IL-8, CSF-1, CCL3, TNF, MCP-1, MCP-2, MCP-3, and MCP-4, were targeted and quantified by Olink multiplex proximity extension assay following the manufacturer’s instructions. The protein abundance levels were reported as normalized protein expression values on a log2 scale.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!